Microstate-based brain network dynamics distinguishing temporal lobe epilepsy patients: A machine learning approach.

Journal: NeuroImage
PMID:

Abstract

Temporal lobe epilepsy (TLE) stands as the predominant adult focal epilepsy syndrome, characterized by dysfunctional intrinsic brain dynamics. However, the precise mechanisms underlying seizures in these patients remain elusive. Our study encompassed 116 TLE patients compared with 51 healthy controls. Employing microstate analysis, we assessed brain dynamic disparities between TLE patients and healthy controls, as well as between drug-resistant epilepsy (DRE) and drug-sensitive epilepsy (DSE) patients. We constructed dynamic functional connectivity networks based on microstates and quantified their spatial and temporal variability. Utilizing these brain network features, we developed machine learning models to discriminate between TLE patients and healthy controls, and between DRE and DSE patients. Temporal dynamics in TLE patients exhibited significant acceleration compared to healthy controls, along with heightened synchronization and instability in brain networks. Moreover, DRE patients displayed notably lower spatial variability in certain parts of microstate B, E and F dynamic functional connectivity networks, while temporal variability in certain parts of microstate E and G dynamic functional connectivity networks was markedly higher in DRE patients compared to DSE patients. The machine learning model based on these spatiotemporal metrics effectively differentiated TLE patients from healthy controls and discerned DRE from DSE patients. The accelerated microstate dynamics and disrupted microstate sequences observed in TLE patients mirror highly unstable intrinsic brain dynamics, potentially underlying abnormal discharges. Additionally, the presence of highly synchronized and unstable activities in brain networks of DRE patients signifies the establishment of stable epileptogenic networks, contributing to the poor responsiveness to antiseizure medications. The model based on spatiotemporal metrics demonstrated robust predictive performance, accurately distinguishing both TLE patients from healthy controls and DRE patients from DSE patients.

Authors

  • Zihan Wei
    College of Computer Science and Technology, Zhejiang University of Technology, Hangzhou, China. Electronic address: 2112012201@zjut.edu.cn.
  • Xinpei Wang
    School of Pharmaceutical Sciences, Shenzhen Campus of Sun Yat-sen University, Shenzhen 518107, China.
  • Chao Liu
    Anti-Drug Technology Center of Guangdong Province, National Anti-Drug Laboratory Guangdong Regional Center, Guangzhou 510230, China.
  • Yan Feng
    Clinical Pharmacology and Pharmacometrics, Bristol-Myers Squibb, Lawrenceville, New Jersey, USA.
  • Yajing Gan
    Department of Neurology, Xijing Hospital, Fourth Military Medical University, 127 West Changle Road, Xi'an 710032, PR China.
  • YuQing Shi
    Jinjiang Third Hospital, Quanzhou 362000, China.
  • Xiaoli Wang
    Demonstration Center of Future Product, Beijing Aircraft Technology Research Institute, COMAC, Beijing, China.
  • Yonghong Liu
    State Key Laboratory of Remote Sensing Science, Center for Global Change and Public Health, College of Global Change and Earth System Science, Beijing Normal University, Beijing, China.
  • Yanchun Deng
    Department of Neurology, Xijing Hospital, Fourth Military Medical University, 127 West Changle Road, Xi'an 710032, PR China. Electronic address: yanchund@fmmu.edu.cn.